Welcome to our dedicated page for Celanese Del SEC filings (Ticker: CE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Celanese Corporation (NYSE: CE) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, including Form 8-K current reports and other documents filed with the U.S. Securities and Exchange Commission. Celanese is a global specialty materials and chemical company in the basic organic chemical manufacturing industry, and its filings offer detailed insight into its financing activities, governance developments and operational decisions.
Recent Form 8-K filings describe a range of material events. Several filings outline registered offerings of senior notes by Celanese US Holdings LLC, a wholly owned subsidiary, including 7.000% Senior Notes due 2031 and 7.375% Senior Notes due 2034. These filings explain that net proceeds are used to repay borrowings under a five-year term loan credit agreement due 2027, fund cash tender offers for outstanding senior notes due 2027 and 2028, and support general corporate purposes, which may include repayment of other indebtedness.
Other 8-K reports cover cash tender offers for the company’s 6.665% Senior Notes due 2027 and 6.850% Senior Notes due 2028, including announcements of the commencement of tender offers, early results and increases in the maximum tender amount and series cap. Additional filings detail a revolving credit agreement providing a five-year unsecured revolving credit facility and an amendment to an existing term loan credit agreement, including new covenant terms.
Celanese filings also document operational and portfolio actions, such as the intended closure of an acetate tow production facility in Lanaken, Belgium, with associated expected non-cash accelerated depreciation and other shutdown costs, and the signing of a purchase and sale agreement to divest the Micromax® portfolio of products. Governance-related filings include the resignation of a Board member and the company’s explanation that the departure was not due to any disagreement on operations, policies or practices.
On Stock Titan, these SEC filings are presented with real-time updates from EDGAR and AI-powered summaries that help explain the key points of each document. Users can quickly understand the implications of Celanese’s 8-K disclosures, senior note offerings, credit agreements, tender offers and other reported events without reading every technical detail.
Celanese Corp Schedule 13G/A amendment: The Vanguard Group reports 0 shares beneficially owned, representing 0% of Common Stock, following an internal realignment. The filing states disaggregated reporting in accordance with SEC Release No. 34-39538 (January 12, 1998). Signed by Ashley Grim on 03/26/2026.
Celanese Corporation and Celanese US Holdings LLC filed a Form S-3 shelf registration on March 25, 2026 to register one or more classes of securities for offering from time to time after the registration statement is declared effective. The prospectus describes common stock, preferred stock, debt securities and guarantees and states that specific terms, aggregate amounts and offering prices will be set forth in prospectus supplements.
The filing identifies certain wholly owned subsidiaries as potential guarantors and discloses authorized capital figures as of February 24, 2026 including 400,000,000 authorized common shares, 170,920,036 issued and 109,571,972 outstanding. The shelf is filed by Celanese as a "well-known seasoned issuer" and permits continuous or delayed offerings under supplemental prospectuses.
Celanese Corp director Kim K.W. Rucker reported a small compensation-related award of phantom stock tied to common shares. On this Form 4, Rucker acquired 5.633 units of phantom stock, each representing the right to receive one share of Celanese common stock. These units reflect dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan. After this award, Rucker holds a total of 9,519.723 phantom stock units, which will be payable in common stock according to the terms of the plan.
Kissire Deborah J. reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Deborah J. Kissire received an automatic award of 3.505 shares of phantom stock tied to deferred compensation dividends. Each phantom stock unit represents the right to receive one share of Celanese common stock under the company’s 2008 Deferred Compensation Plan. Following this grant, she holds a total of 5,924.793 phantom stock units directly, which will eventually be settled in common shares as provided in the plan. This filing reflects routine compensation-related accruals rather than an open-market stock purchase or sale.
Celanese Corp director Jay V. Ihlenfeld received a small phantom stock award as part of deferred compensation. On this date, he acquired 6.0600 phantom stock units, each representing the right to receive one share of Celanese common stock. These units reflect dividend equivalents on compensation deferred under the company’s 2008 Deferred Compensation Plan and will be paid in common shares according to that plan’s terms. Following this grant, Ihlenfeld directly holds a total of 10241.1190 phantom stock units linked to Celanese common stock.
Celanese Corp director Kathryn Hill reported an acquisition of 0.675 shares of phantom stock on March 10, 2026. This entry reflects dividend equivalents credited on compensation deferred under Celanese’s 2008 Deferred Compensation Plan. Each phantom share represents the right to receive one share of Celanese common stock, bringing her total phantom holdings to 1,141.194 shares.
GALANTE EDWARD G reported acquisition or exercise transactions in this Form 4 filing.
Celanese Corp director Edward G. Galante received a small grant of 4.028 phantom stock units on Celanese common stock. These units were credited as dividend equivalents on compensation he deferred under the company’s 2008 Deferred Compensation Plan and are settled in common shares under that plan’s terms.
Following this award, Galante holds a total of 6,806.793 phantom stock units tied to Celanese common stock. This filing reflects a routine, compensation-related accrual rather than an open-market purchase or sale of shares.
Celanese Corporation is asking shareholders to vote on key governance and compensation items at its 2026 virtual annual meeting. Shareholders will elect nine directors to one-year terms, ratify KPMG LLP as independent auditor for 2026, and cast an advisory vote on executive compensation.
The proxy highlights an actively refreshed, largely independent Board, with 8 of 9 nominees independent and an independent Chair. It emphasizes strong governance features such as annual director elections, majority voting, proxy access, no supermajority provisions and no poison pill, plus robust shareholder engagement.
Celanese reports 2025 net sales of $9,544 million, a GAAP diluted loss per share of $(10.44), adjusted EPS of $3.98, a net loss of $1,165 million, operating EBITDA of $1,893 million, operating cash flow of $1,146 million and free cash flow of $773 million, and frames these results within a strategy focused on free cash flow, deleveraging, portfolio optimization and long-term value creation.
Celanese Corporation reported that on February 27, 2026, Timothy Go resigned from its Board of Directors, effective the same day. The company states that his resignation was not due to any disagreement regarding operations, policies, or practices. The Board and the company expressed appreciation for his service as a director.